Bioxcel TherapeuticsBTAIQ
13F holders, Q1 2026 (March 31)At the end of Q1 2026, 40 institutions reported holding Bioxcel Therapeutics Inc. (BTAIQ) in their 13F filings, down 1 from Q4 2025. 5 opened new positions and 8 sold out. The largest holders were Millennium Management ($2.6M), Armistice Capital, LLC ($2.6M) and Oaktree Capital Management ($323K). 2 famous investors held it, including Howard Marks (0.0% of Oaktree Capital Management's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Bioxcel Therapeutics Inc.
- CUSIP
- 09075P204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $2.7M |
| Exits | 8 | $495K |
All 13F filers, Q4 2025 → Q1 2026: 2,230,113 shares bought and 325,977 shares sold, net +1,904,136 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 40 holders
| Millennium Management | 0.00% | Add +5.5% | 1,936,760 | $2.6M |
| Armistice Capital, LLC | 0.08% | New | 1,910,076 | $2.6M |
| Oaktree Capital Management | 0.01% | No change | 241,188 | $323K |
| Geode Capital Management, LLC | 0.00% | Add +11.6% | 230,168 | $309K |
| Vanguard Capital Management LLC | 0.00% | — | 207,339 | $278K |
| Jones Financial Companies LLLP | 0.00% | Reduce -4.3% | 131,789 | $166K |
| Man Group plc | 0.00% | Add +69.8% | 96,473 | $129K |
| State Street Corp. | 0.00% | Add +45.7% | 92,118 | $123K |
| FMR LLC | 0.00% | No change | 90,300 | $121K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 84,921 | $114K |
| BlackRock, Inc. | 0.00% | Reduce -0.1% | 84,282 | $113K |
| &partners | 0.00% | New | 80,864 | $108K |
| UBS Group AG | 0.00% | Add +37.7% | 52,788 | $71K |
| Oaktree Fund Advisors, LLC | 0.10% | No change | 42,913 | $58K |
| HighTower Advisors, LLC | 0.00% | No change | 41,000 | $55K |
| Northern Trust Corp. | 0.00% | Reduce -5.4% | 36,313 | $49K |
| Beacon Pointe Advisors, LLC | 0.00% | New | 18,877 | $25K |
| Osaic Holdings, Inc. | 0.00% | Add +3.0% | 16,214 | $22K |
| Portfolio Strategies, Inc. | 0.00% | No change | 12,178 | $16K |
| Diversify Wealth Management, LLC | 0.00% | No change | 15,000 | $16K |
| Morgan Stanley | 0.00% | Add +623.2% | 10,588 | $14K |
| Wells Fargo & Company | 0.00% | Reduce -0.1% | 4,319 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 1,718 | $2K |
| NewEdge Advisors, LLC | 0.00% | No change | 1,331 | $2K |
| Vanguard Global Advisers, LLC | 0.00% | — | 493 | $661 |
| Silver Grove Financial Group, Inc. | 0.00% | New | 334 | $447 |
| Washington Trust Advisors, Inc. | 0.00% | No change | 160 | $214 |
| Annis Gardner Whiting Capital Advisors, LLC | 0.00% | Add +39.3% | 156 | $210 |
| Parkside Financial Bank & Trust | 0.00% | No change | 112 | $151 |
| EverSource Wealth Advisors, LLC | 0.00% | No change | 60 | $80 |
| BNP Paribas Financial Markets | 0.00% | Add +391.7% | 59 | $79 |
| JPMorgan Chase & Co. | 0.00% | No change | 45 | $54 |
| Farther Finance Advisors, LLC | 0.00% | No change | 25 | $31 |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 21 | $28 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -91.7% | 14 | $19 |
| IFP Advisors, Inc | 0.00% | Reduce -99.7% | 13 | $17 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0.00% | No change | 2 | $3 |
| US Bancorp \de | 0.00% | No change | 1 | $1 |
| Group One Trading LLC | 0.00% | Reduce -100.0% | 1 | $1 |
| Triumph Capital Management | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is BTAIQ's weight in each manager's 13F, not the share of Bioxcel Therapeutics Inc. the manager owns.